Cargando…

Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab

Detalles Bibliográficos
Autor principal: Imaging, Contrast Media & Molecular
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397468/
https://www.ncbi.nlm.nih.gov/pubmed/37547638
http://dx.doi.org/10.1155/2023/9781974
_version_ 1785083916199133184
author Imaging, Contrast Media & Molecular
author_facet Imaging, Contrast Media & Molecular
author_sort Imaging, Contrast Media & Molecular
collection PubMed
description
format Online
Article
Text
id pubmed-10397468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103974682023-08-04 Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab Imaging, Contrast Media & Molecular Contrast Media Mol Imaging Retraction Hindawi 2023-07-26 /pmc/articles/PMC10397468/ /pubmed/37547638 http://dx.doi.org/10.1155/2023/9781974 Text en Copyright © 2023 Contrast Media & Molecular Imaging. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Imaging, Contrast Media & Molecular
Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
title Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
title_full Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
title_fullStr Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
title_full_unstemmed Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
title_short Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
title_sort retracted: analysis of the relationship between scleritis and t cell activation in patients with hepatocellular carcinoma treated with pd-1 carrelizumab
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397468/
https://www.ncbi.nlm.nih.gov/pubmed/37547638
http://dx.doi.org/10.1155/2023/9781974
work_keys_str_mv AT imagingcontrastmediamolecular retractedanalysisoftherelationshipbetweenscleritisandtcellactivationinpatientswithhepatocellularcarcinomatreatedwithpd1carrelizumab